Primary Site >> Colorectal Cancer
Gene >> EPOR
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis. PMID: 16288305 |
Ref: Serum erythropoietin and angiogenetic factors in human colorectal cancer. PMID: 18780647 |
Ref: Erythropoietin and erythropoietin receptor in colorectal cancer. PMID: 18487221 |
Ref: Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer. PMID: 19846965 |
Ref: Effect of erythropoietin, 5-fluorouracil and SN-38 on the growth of DLD-1 cells. PMID: 21098876 Ref: Thrombopoietin receptor levels in tumor cell lines and primary tumors. PMID: 21318160 |
Ref: Downregulation of erythropoietin receptor by overexpression of phospholipase C-gamma 1 is critical for decrease on focal adhesion in transformed cells. PMID: 21360263 Ref: Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis. PMID: 21623073 |
Ref: The relationships between hypoxia-dependent markers: HIF-1alpha, EPO and EPOR in colorectal cancer. PMID: 24497137 |
Ref: Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts. PMID: 27543111 Ref: Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions? PMID: 27959268 |
Ref: Erythropoietin Enhances the Cytotoxic Effect of Hydrogen Peroxide on Colon Cancer Cells. PMID: 27903235 Ref: Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production. PMID: 29078273 |